Study to Assess Efficacy and Safety of Three Oral Doses of Laquinimod

Study Title
A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod
Teva Identifier
TV5600-CNS-20007 | 2014-000418-75
ClinicalTrials.gov Identifier
NCT02215616
Study Status
Completed
Trial Condition(s)
Huntington's Disease
Interventions
Drug: Laquinimod | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
21 Years to 55 Years
Trial Duration
October 28, 2014 - June 19, 2018
Phase
Phase 2

Study Type

Interventional